They found that prominent CE accumulation, which only occurred in advanced prostate cancer, is a consequence of the loss of tumour suppressor PTEN and subsequent activation of the PI3K/AKT/mTOR pathway. The gene discussed is PTEN; the disease is prostate cancer.